These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11844944)

  • 1. Locus of control orientation in panic disorder and the differential effects of treatment.
    Bakker A; Spinhoven P; van der Does AJ; van Balkom AJ; van Dyck R
    Psychother Psychosom; 2002; 71(2):85-9. PubMed ID: 11844944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?
    Dusseldorp E; Spinhoven P; Bakker A; van Dyck R; van Balkom AJ
    Psychother Psychosom; 2007; 76(3):154-61. PubMed ID: 17426414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive therapy by allocation versus cognitive therapy by preference in the treatment of panic disorder.
    Bakker A; Spinhoven P; van Balkom AJ; Vleugel L; van Dyck R
    Psychother Psychosom; 2000; 69(5):240-3. PubMed ID: 10965288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
    Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
    Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term treatment of panic disorder.
    Davidson JR
    J Clin Psychiatry; 1998; 59 Suppl 8():17-21; discussion 22-3. PubMed ID: 9707158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K; Griez E
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of panic disorder: focus on paroxetine.
    Pollack MH; Doyle AC
    Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
    Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
    Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
    J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-efficacy of individual and combined treatments for panic disorder.
    McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of assessment of cognitions during panic attacks in the treatment of panic disorder.
    Bakker A; Spinhoven P; van Balkom AJ; van Dyck R
    Psychother Psychosom; 2002; 71(3):158-61. PubMed ID: 12021558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.
    Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD
    Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endurance training in panic patients: spiroergometric and clinical effects.
    Meyer T; Broocks A; Bandelow B; Hillmer-Vogel U; Rüther E
    Int J Sports Med; 1998 Oct; 19(7):496-502. PubMed ID: 9839848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental cost-effectiveness of pharmacotherapy and two brief cognitive-behavioral therapies compared with usual care for panic disorder and noncardiac chest pain.
    Poirier-Bisson J; Marchand A; Pelland ME; Lessard MJ; Dupuis G; Fleet R; Roberge P
    J Nerv Ment Dis; 2013 Sep; 201(9):753-9. PubMed ID: 23995030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
    Reznik AM; Arbuzov AL; Khurbatova IG
    Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
    Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.